Skyline Medical Signs Letter of Intent to Form Joint

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Skyline Medical Signs Letter of Intent to Form Joint Venture with Electronic On-Ramp
  • New entity will provide access to bid for $550 million in U.S. federal government funds with a focus on medical equipment for mobile operating rooms
  • Skyline Medical to hold conference call on September 8 , 2016 at 12:00 p.m. Eastern time

MINNEAPOLIS, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ: SKLN ) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, announces the signing of a letter of intent to form a joint venture with Electronic On-Ramp, Inc. (EOR), a Native American Indian, (8a) certified Small Disadvantaged Business owned by a Service Disabled Veteran.  EOR's Partner contracts with the U.S. National Institutes of Health (NIH) and Department of Defense are expected to provide Skyline Medical with access to bid on procurement contracts for up to $550 million or more in federal funds budgeted for health, security, life safety systems support, humanitarian assistance and disaster preparedness.

The joint venture is subject to definitive agreements. Also, the joint venture cannot proceed unless the Company receives FOR votes representing a majority of Skyline Medical common shares outstanding on the first two proxy items for the Special Meeting of Stockholders to be held September 15, 2016.  Those items include proposals to 1) increase the number of authorized shares of common stock to 200,000,000 from 100,000,000, and 2) effect a reverse stock split of its common stock at a ratio of between one-for-two and one-for-25 and a proportionate decrease in the number of authorized shares of common stock.

The two companies are establishing the joint venture to be in operation by the end of the year.  The joint venture, expected to be 51% owned by EOR, will bid to supply medical products for mobile operating rooms, among other activities.  Skyline intends to assist the venture in selling the STREAMWAY System and in sourcing other medical products to fulfill bids to the U.S. government, with the venture’s control structured to maintain its standing as a qualified government contractor.

“We are very excited to enter into this new joint venture with EOR as it provides access to significant federal, state and local funds some 18 months ahead of Skyline’s previous plan, and advances our strategy to increase our operating room footprint,” said Dr. Carl Schwartz, Interim Chief Executive Officer of Skyline Medical. “EOR has pre-negotiated contractual terms with the General Services Administration (GSA) for two contracts that afford Skyline immediate entrée to two schedules that provide access to highly efficient sales tools, entering a market for contractor awards of more than $15.8 billion in contracts last year alone.”

Dr. Schwartz added, “In addition to the joint venture bringing immediate access to existing contract vehicles, EOR and Skyline will work together to add contract vehicles specifically targeting environmental services and medical devices, a market with awards of $6 billion last year.  These joint efforts will culminate in access to the market for $33 billion that federal, state and local government buyers spent through GSA schedule contracts in the fiscal year ended September 30, 2015.”

The two primary contracts EOR will utilize to promote sales of Skyline medical devices, services and other technical solutions include the $14.5 billion GSA Information Technology Schedule 70 contract, the largest GSA contract offered. The second contract EOR provides is the Security and Life Safety Schedule 84, which received more than $1.3 billion in contracts during fiscal year 2015.

Commenting on the joint venture, William Pullen, President of Electronic On-Ramp, said, “The STREAMWAY System will be the anchor product in our new venture, and utilizing our deep expertise working as a government contractor we foresee exciting opportunity.  We look forward to tapping into Skyline’s medical device expertise to become a powerhouse supplier to the U.S. government not only of STREAMWAY, which is clearly needed in mobile operating rooms to mitigate exposure to contaminated body fluid waste, but also to identify and source additional medtech product opportunities.”

To date, EOR has been awarded two contracts including one with the NIH to provide government-wide health-related security, technology and information support, and one with the U.S. Southern and Northern Commands to provide operating room and medical equipment for the government for disaster relief efforts for North America and South America. 

In addition to direct opportunities via the EOR joint venture, Skyline will bid jointly with the venture or separately where its distribution agreement with MUNRO Enterprises, an Economically-Disadvantaged, Woman-Owned Small Business, is helpful in qualifying for projects. Skyline anticipates a more robust relationship with EOR in the future, including exploration of further strategic partnerships and other relationships between the companies.

Conference Call and Webcast

Skyline Medical management will host a conference call beginning at 12:00 p.m. Eastern time on September 8, 2016 to discuss this announcement and answer questions.  To access the call, dial (844) 751-1093 from within the U.S. or (574) 990-2954 from outside the U.S.  All listeners should provide passcode 73407900.  Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company's website at www.skylinemedical.com .

Following the conclusion of the conference call, a telephone replay will be available through 11:59 p.m. Eastern time September 14, 2016 and can be accessed by dialing (855) 859-2056 from within the U.S. or (404) 537-3406 from outside the U.S.  All listeners should provide passcode 73407900.  The webcast will be available for 30 days.

About the STREAMWAY System

Skyline's revolutionary, FDA-cleared STREAMWAY system is the first true direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. It connects directly to a facility's plumbing system to automate the collection, measurement and disposal of waste fluids.  As of June 30, 2016, Skyline Medical customers have installed 94 STREAMWAY systems in 50 facilities across 19 states.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. It also provides unlimited capacity for increased efficiency in the operating room, which leads to greater profitability. Furthermore, the STREAMWAY eliminates canisters to reduce overhead costs and provides greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the U.S.  For a demonstration please visit www.skylinemedical.com or call (855) 785-8855.

About Electronic On-Ramp, Inc.

The Electronic On-Ramp, Inc. is a Native American Indian, (8a) certified Small Disadvantaged Business with primary offices located in a HubZone. EOR is owned by a Service Disabled Veteran (VOSB / SDVOB). EOR is skilled in providing architectural, engineering, information assurance, intelligence, counter-intelligence and forensics products and services. EOR specializes in complete lifecycle solutions and in helping the “good guys” from around the world with assessments, evaluations, remediation, configuration management, monitoring and security enhancements, and in building integrated Secure Network Operation Centers (iSNOC) with a focus on detecting covert communications channels and reducing insider threat.

About Skyline Medical

Skyline Medical produces a fully automated, patented, FDA-cleared waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods that require hand carrying and emptying filled fluid canisters present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers; 2) improve compliance with OSHA and other regulatory agency safety guidelines; 3) improve efficiency in the operating room, and radiology and endoscopy departments, thereby leading to greater profitability; and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills each year in the U.S.  For additional information, please visit www.skylinemedical.com .

Forward-looking Statements

Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the Company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable, adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov.  This is not a solicitation to buy or sell securities and does not purport to be an analysis of the Company's financial position. See the Company's most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov .

Contacts: LHA Kim Sutton Golodetz kgolodetz@lhai.com (212) 838-3777    or Bruce Voss bvoss@lhai.com (310) 691-7100

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 144

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 263

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 159

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 242

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 327

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

2026 Honors Shaping Leadership Through Innovation

Updated Category News Views 52

Frost & Sullivan Institute: Leading By Example Alright, folks, we’re talking about the kind of business leadership that isn’t just about fattening the bottom line. The Frost & Sullivan Institute rolled out the carpet for companies that don’t just talk the talk—they walk the walk. This recognition isn't just another plaque for the wall; it's a pat on the back for...

Continue Reading
Boosting Franchise Performance Through Gamification with Batteries Plus

Updated Category News Views 204

Revolutionizing Franchise Excellence: The Plus Games Batteries Plus, a leader in the battery retail sector, has embarked on an exciting journey with its newly announced initiative called The Plus Games. This program is designed to transform franchisee training and sales strategies by gamifying the entire process. The objective? To cultivate exceptional performance and...

Continue Reading
Investigation into Eos Energy Enterprises' Potential Securities Fraud

Updated Category News Views 213

Investigation into Eos Energy Enterprises Pomerantz LLP is currently investigating claims concerning investors of Eos Energy Enterprises, Inc. (NASDAQ: EOSE). This inquiry raises questions about whether the company and some of its executives may have been involved in securities fraud or other fraudulent business practices. Recent Developments at Eos Energy Recently, Eos...

Continue Reading
Emerging Trends Transforming the Global Cold Brew Coffee Market

Updated Category News Views 184

Impact of Millennial Preferences on Cold Brew Coffee The cold brew coffee market is poised for significant growth, estimated to expand by USD 519.2 million within the forecast period. This growth is largely driven by changing consumer preferences, particularly among millennials who favor modern, convenient beverage choices. As more companies enter the market with...

Continue Reading
EMCOR Group, Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 74

EMCOR Group, Inc. Announces Quarterly Cash Dividend NORWALK, Conn. - EMCOR Group, Inc. (NYSE: EME) has proudly declared a regular quarterly cash dividend of $0.25 per common share. This announcement was made by the Board of Directors, showing their ongoing commitment to delivering value to shareholders. Dividend Payment Details The scheduled payment date for the upcoming...

Continue Reading